{"schema_version":"secwatch.filing_event.v1","accession":"0001639691-23-000087","form_type":"8-K","ticker":"LIVN","cik":"0001639691","company_name":"LivaNova PLC","filed_at":"2023-09-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.649025+00:00","generated_at":"2026-06-10T10:45:15.153083+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"LivaNova Cardiopulmonary President Marco Dolci to retire Dec 31, 2023, receives €860,000","bullets":["Marco Dolci, President of the Cardiopulmonary business unit, announced retirement effective Dec 31, 2023.","Retirement settlement includes €860,000 payment under Italian law and continued vesting of unvested equity awards.","Mr. Dolci will remain in his role through the retirement date to support transition; he joined LivaNova in March 2017."],"urls":{"canonical":"https://secwatch.observer/filing/0001639691-23-000087","json":"https://secwatch.observer/filing/0001639691-23-000087.json","markdown":"https://secwatch.observer/filing/0001639691-23-000087.md","text":"https://secwatch.observer/filing/0001639691-23-000087.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1639691/000163969123000087/0001639691-23-000087-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1639691/000163969123000087/livanovaform8-kdolci.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T10:45:15.153083+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1c52b639fc","claim":"Marco Dolci departed as President, Cardiopulmonary Business Unit at LivaNova PLC.","evidence_excerpt":"On September 21, 2023, LivaNova PLC (the “Company”) reported that Marco Dolci, President of the Company’s Cardiopulmonary Business Unit, announced his intent to retire formally from the Company on December 31, 2023 (the “Retirement Date”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1639691/000163969123000087/0001639691-23-000087-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"retire"},{"label":"Role","value":"President, Cardiopulmonary Business Unit"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}